Erratum to "Risk assessment of topically applied products" [Toxicology 236 (2007) 140-148] (DOI:10.1016/j.tox.2007.04.011);Risk assessment of topically applied products

Toxicology

Volumn 236, Issue 1-2, 2007, Pages 140-148

  Søeborg, Tue ^a   Basse, Line Hollesen ^b   Halling Sørensen, Bent ^a  

^a DANISH MEDICINES AGENCY   (Denmark)

^b LEO PHARMA A S   (Denmark)

Author keywords

3 BC; 4 MBC; BADGE; Extractable; Flux; In vitro; Leachable; Skin permeation; Sunscreen; Tape stripping

Indexed keywords

2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; 3 BENZYLIDENE CAMPHOR; 4 METHYLBENZYLIDENE CAMPHOR; ETHER DERIVATIVE; SUNSCREEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREAM; DRUG DOSAGE FORM; DRUG TOLERABILITY; ENDOCRINE DISEASE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; SKIN; SKIN ABSORPTION; SKIN DISEASE; SKIN PERMEABILITY; SUNLIGHT PROTECTION; SWINE; ULTRAVIOLET RADIATION; WOUND;

SUIDAE;

EID: 34249088386     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.05.023     Document Type: Erratum

References (31)

1. Autier P., Boniol M., Severi G., and Dore J.F. Quantity of sunscreen used by European students. Br. J. Dermatol. 144 2 (2001) 288-291
2. Boogaard P.J., Denneman M.A., and van Sittert N.J. Dermal penetration and metabolism of five glycidyl ethers in human, rat and mouse skin. Xenobiotica 30 5 (2000) 469-483
3. British Pharmacopoeia Commission. British Pharmacopoeia 2003 (2003), The Stationary Office, London
4. Cancer Council Australia, 2006. Sunscreen. Personal Communication (31-8-2006).
5. Choi M.J., and Maibach H.I. Role of ceramides in barrier function of healthy and diseased skin. Am. J. Clin. Dermatol. 6 4 (2005) 215-223
6. Cohen D.E., and Rice R.H. Toxic responses in the skin. In: Klaassen C.D. (Ed). Casarett & Doull's Toxicology. The Basic Science of Poisons. 6th ed. (2001), McGraw-Hill, New York 653-672
7. Durrer S., Maerkel K., Schlumpf M., and Lichtensteiger W. Estrogen target gene regulation and coactivator expression in rat uterus after developmental exposure to the ultraviolet filter 4-methylbenzylidene camphor. Endocrinology 146 5 (2005) 2130-2139
8. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80 (1983) 44s-49s
9. European Commission, 1998. Opinion of the scientific committee on cosmetic and non-food products intended for consumers concerning 3-benzylidenebornan-2-one adopted by the plenary session of 21 January 1998. XXIV/1374/96, rev. 1/98. European Commission.
10. European Commission, 2004a. Guidance document on dermal absorption. Sanco/222/2000 rev. 7.
11. European Commission, 2004b. Scientific committee on cosmetic products and non-food products intended for consumers opinion concerning 4-methylbenzylidene camphor. SCCNFP/0779/04.
12. European Commission. Commission regulation (EC) No 1895/2005 of 18 November 2005 on the restriction of use of certain epoxy derivatives in materials and articles intended to come into contact with food. Official J. Eur. Union L 302 (2005) 28-32
13. European Commission, 2006. The SCCP's notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 6th revision, SCCP (report available on http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_03j.pd f).
14. Gupta V.K., Zatz J.L., and Rerek M. Percutaneous absorption of sunscreens through micro-yucatan pig skin in vitro. Pharm. Res. 16 10 (1999) 1602-1607
15. Induchem A.G., 2006. Products/sun protection. http://www.induchem.com/ (13-9-2006).
16. Janjua N.R., Mogensen B., Andersson A.-M., Petersen J.H., Henriksen M., Skakkebæk N.E., and Wulf H.C. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J. Invest. Dermatol. 123 (2004) 57-61
17. KemI. Human Health Risk Assessment. Proposals for the use of Assessment (Uncertainty) Factors. Application to Risk Assessment for Plant Protection Production, Industrial Chemicals and Biocidal Products within the European Union. Body for Competence and Methodology Development (2003), National Chemicals Inspectorate and Institute of Environmental Medicine Karolinska Institutet, Solna, Sweden
18. Kunz P.Y., Gries T., and Fent K. The ultraviolet filter 3-benzylidene camphor adversely affects reproduction in fathead minnow (Pimephales promelas). Toxicol. Sci. 93 (2006) 311-321
19. Madison K.C. Barrier function of the skin: "La Raison d'Être" of the epidermis. J. Invest. Dermatol. 121 2 (2003) 231-241
20. Melnik B.C., Hollmann J., Erler E., Verhoeven B., and Plewig G. Microanalytical screening of all major stratum corneum lipids by sequential high-performance thin-layer chromatography. J. Invest. Dermatol. 92 2 (1989) 231-234
21. OECD, 2004. Guidance Document for the Conduct of Skin Absorption Studies. OECD, Paris. Report no. 28 (ENV/JM/MONO(2004)2).
22. Rastogi S.C. UV filters in sunscreen products-a survey. Contact Dermatit. 46 (2002) 348-351
23. Schauer U.M.D., Volkel W., Heusener A., Colnot T., Broschard T.H., von Landenberg F., and Dekant W. Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application. Toxicol. Appl. Pharmacol. 216 2 (2006) 339-346
24. Schlumpf M., Cotton B., Conscience M., Haller V., Steinmann B., and Lictensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ. Health Perspect. 109 3 (2001) 239-244
25. Schlumpf M., Schmid P., Durrer S., Conscience M., Maerkel K., Henseler M., Gruetter M., Herzog I., Reolon S., Ceccatelli R., Faass O., Stutz E., Jarry H., Wuttke W., and Lictensteiger W. Endocrine activity and developmental toxicity of cosmetic UV filters-an update. Toxicology 205 1/2 (2004) 113-122
26. Scientific Panel on Food Additives F.P.A.a.M.i.C.w.F.A. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to 2,2-bis(4-hydroxyphenyl)propane bis(2,3-epoxypropyl)ether (bisphenol A diglycidyl ether, BADGE). EFSA J. 86 (2004) 1-40
27. Søeborg T., Ganderup N.-C., Kristensen J.H., Bjerregaard P., Pedersen K.L., Bollen P., Hansen S.H., and Halling-Sørensen B. Distribution of the UV filter 3-benzylidene camphor in rat following topical application. J. Chromatogr. B 834 (2006) 117-121
28. Søeborg T., Hansen S.H., and Halling-Sørensen B. Determination of bisphenol diglycidyl ethers in topical dosage forms. J. Pharm. Biomed. Anal. 40 2 (2006) 322-330
29. Timbrell J. Principles of Biochemical Toxicology. 3rd ed. (2005), Taylor & Francis, New York
30. Tsai J.-C., Sheu H.-M., Hung P.-L., and Cheng C.-L. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: implications for the permeability of compromised skin. J. Pharm. Sci. 90 9 (2001) 1242-1254
31. WHO, 2005. Chemical-specific Adjustment Factors for Interspecies Differences and Human Variability: Guidance Document for Use of Data in Dose/Concentration-response Assessment. WHO Press, Geneva, Switzerland.